DOR BioPharma Reports Achievement Of Two-Year Stability Milestone For RiVax(TM), Its Vaccine Against Ricin Toxin

DOR BioPharma, Inc. (OTCBB: DORB) announced that it has successfully achieved a two-year milestone in the long-term stability program of the key ingredient of RiVax?, a recombinant subunit vaccine against ricin toxin. RiVax? is intended to protect against exposure to ricin toxin that might result from the purposeful release of ricin in an aerosolized form, or as a poisonous contaminant in food or water.

More: continued here

Filed under: Bio-terrorism on February 7th, 2008